2Regenold WT, Thapar RK, Marano C, etal. Increased prevalence of type Ⅱ diabetes mellitus among psychiatric inpatients with bipolar affective and schizoaffective disorders independent of psychotropicdrug use.J Affect Disord 2002;70(1):19-26.
3Prestele S, Aldenhoff, Reiff J, et al. The HAP - axis as a Possible Link between Depression, diabetes MeUitus and Congnitive Dysfunction. Fortschr Neurol Psychair 2003 ;71(1) :24 - 36.
9Bschor T, Baethge C, Adli M, et al. Hypothalamie - pituitary-thyroid system activity during lithium augmentation therapy in patients with unipolar major.J psychiatry Neurosci 2003;28(3) :210-216.
10Frayn KN. Adipose tissue and the insulin resistance syndrome [J]. Proc Nutr Society 2001;60(3) :375 - 380.
3Marin P, DarinN, Amamiya T, et al. Cortisol secretion inrelation to body fat discribution in obese premenopausal women. Metabolism. 1992,41(8):882.
4King BM, Banta AB, Tharel GN, et al. Hypothalamic hyperinsulinemia and obesity: oral of adrenal glucocortiecids. Am J Physio. 1983, 24(2):E194.
5Cameron OG, Thomas B, Tiongco D, et al. Hypercortisolism in diabetes mellitus. Diabetes Care. 1987, 10:662.
6Rothermundt M, Arolt V, Peters M, et al.Inflammatory markers in major depression and melancholia. J Affect Disord 2001;63(1-3):93-102
7Maes M, Vandoolaeghe E, Neels H, et al.Lower serum zinc in major depression is a sensitive marker of treatment resistance and of the immune/inflammatory response in that illness. Biol Psychiatry 1997;42(5):349-58
8Maes M,De Vos N, Demedts P, et al.Lower serum zinc in major depression in relation to changes in serum acute phase proteins.J Affect Disord 1999; 56(2-3):189-94
9Rothermundt M, Arolt V, Fenker J, et al.Different immune patters in melancholic and non-melancholic major depression. Eur Arch Psychiatry Clin Neurosci 2001;251(2):90-7
10Natelson BH, Denny TN, Zhou XD, et al.Is depression associated with immune activation? J Affect Disord 1999;53(2): 179-84
